Directive - General
Direktif untuk semua produk statin: Memperkukuhkan amaran berkaitan risiko kesan advers kognitif dan peningkatan HbA1c serta fasting blood glucose (FBG)
Written by LIM SZE GEE · 24 September 2014
Document not available
The file for this publication is not currently available online. Contact NPRA if you need a copy.